Arkolith/Insider Trading/COGT/Form 4

Fairmount Funds Management LLC

DirectorCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Mar 31, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$242.6M
Net Open-Market Flow
-$242.6M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2026Conversion(C)7.0M——12.5M
Mar 31, 2026Sell(S)7.0M$34.66$242.6M5.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2026Conversion(C)28K—$039K

Transaction Codes

C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-038057) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML